(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 1 Examiner Use of Background Statements David Schnapf Sheppard Mullin Richter & Hampton.

Slides:



Advertisements
Similar presentations
Technology Center 1600 Training on Writing Rejections Under 35 U.S.C. § 103.
Advertisements

Anatomy of a Patent Application Presented by: Jeong Oh Director, Office of Technology Transfer & Industrial Development Syracuse University April 30, 2009.
Proteomics Examination Yvonne (Bonnie) Eyler Technology Center 1600 Art Unit 1646 (703)
October 2007KSR Training1 TC 3700 KSR Sample Rejection.
More on Restriction Practice Jim Housel SPE, Art Unit 1648 (703)
INTRODUCTION TO PATENT RIGHTS The Business of Intellectual Property
Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting October 8, 2002 William F. Smith Administrative Patent Judge Board of Patent Appeals.
UNITED STATES PATENT AND TRADEMARK OFFICE A full transcript of this presentation can be found under the “Notes” Tab. Claim Interpretation: Broadest Reasonable.
1 Rule 132 Declarations and Unexpected Results Richard E. Schafer Administrative Patent Judge Board of Patent Appeals and Interferences.
G & B Seminar 2006 Duty of Disclosure for Enforceable/Valid U.S. Patents Daniel Moon.
Patent, Trademark, Copyright, and Enforcement - Law and Policy November 5-8, 2007 United States Patent and Trademark Office Global Intellectual Property.
1 35 USC 112, 1 st paragraph enablement Enablement Practice in TC 1600 Deborah Reynolds, SPE
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
35 U.S.C. 112, Sixth Paragraph MPEP 2181 – 2186 Jean Witz Quality Assurance Specialist Technology Center 1600.
Filing Compliant Reexam Requests Andy Kashnikow SPE, Central Reexamination Unit Andy Kashnikow SPE, Central Reexamination Unit June, 2010.
1 Principles in Restriction Practice TC 1600 Anthony Caputa TC Practice Specialist (571)
Memorandum - 35 U.S.C. 112, Second and Sixth Paragraphs Robert Clarke Director, Office of Patent Legal Administration United States Patent and Trademark.
J. Gordon Thomson Professional Corporation Barrister, Solicitor & Notary Public (Ontario) Registered Patent Agent (Canada & USA) Registered Trade-mark.
“REACH-THROUGH CLAIMS”
Determination of Obviousness Practice Under the Genus-Species Guidelines and In re Ochiai; In re Brouwer Sreeni Padmanabhan & James Wilson Supervisory.
Restriction Practice for Genus Claims Species Claims Linking Claims and Markush Claims Julie Burke QAS/PM TC1600.
Determining Obviousness under 35 USC 103 in view of KSR International Co. v. Teleflex TC3600 Business Methods January 2008.
by Eugene Li Summary of Part 3 – Chapters 8, 9, and 10
Intellectual Property Boston College Law School March 3, 2008 Patent - Nonobviousness.
Patent Overview by Jeff Woller. Why have Patents? Patents make some people rich – but, does that seem like something the government should protect? Do.
CENTER FOR ADVANCED STUDY & RESEARCH ON INTELLECTUAL PROPERTY 2002 HIGH TECHNOLOGY PROTECTION SUMMIT Ethical Issues In Patent Law Inequitable Conduct –
® ® From Invention to Start-Up Seminar Series University of Washington The Legal Side of Things Invention Protection Gary S. Kindness Christensen O’Connor.
A comparative analysis with a harmonizing perspective A RT. 123(2) EPC AND US W RITTEN D ESCRIPTION 1 © AIPLA 2015 Enrica Bruno - Steinfl & Bruno LLP.
1 Basic Facts about Patents Chem 3380 Fall Patent Documents  Legal Document A patent is a legal right granted by a government to an inventor.
PatentEng-Berkeley-Lavian Week 7: Anticipation and Obviousness 1 Patent Engineering IEOR 190G CET: Center for Entrepreneurship &Technology Week 7 Dr. Tal.
Stem Cells Peter Paras, Jr.. 2 Overview Introduction — Definitions Types of Stem Cells — Origin Examination of Stem Cell Claims — Statutes — Sample Claims.
Information Disclosure Statements
Protect Your Patents from Inequitable Conduct Charges July 22, 2010.
1 ANTICIPATION BY INHERENCY IN PRIOR ART James O. Wilson Supervisory Patent Examiner Technology Center 1600 USPTO (571)
Broadening the Scope of the Claims in Gene Therapy Applications Deborah Reynolds Detailee, TCPS
Professor Peng  Patent Act (2008) ◦ Promulgated in 1984 ◦ Amended in 1992, 2000, and 2008.
Routine Optimization Jean Witz, tQAS, TC
To Restrict or Not To Restrict That Is The Question? Divided We Stand! Or Undivided We Stand!! By Joseph K. McKane SPE, Art Unit 1626.
Overcoming Prior Art References Non-Enabling Prior Art References Gary Kunz SPE Art Unit 1616.
19/19/07132 Declarations 37 CFR § Practice GENERAL INTRODUCTION.
Appeals in patent examination and opposition in Germany Karin Friehe Judge, Federal Patent Court, Munich, Germany.
CIVILITY AND BEST PRACTICES IN PROSECUTION INTERACTIONS Esther Kepplinger Wilson Sonsini Goodrich & Rosati BCP September 5, 2012.
1 When is it NOT Appropriate to Restrict? Julie Burke TC1600 QAS
New Sections 102 & 103 (b) Conditions for Patentability- (1) IN GENERAL- Section 102 of title 35, United States Code, is amended to read as follows: -`Sec.
Patentability Considerations in the 3-D Structure Arts Patentability Considerations in the 3-D Structure Arts Michael P. Woodward Supervisory Patent Examiner.
Overview Validity of patent hinges on novelty, utility, and non-obviousness Utility generally not an issue Pre-suit investigation focuses on infringement,
3 rd Party Participation Bennett Celsa TC 1600 QAS.
1 Demystifying the Examination of Stem Cell-Related Inventions Remy Yucel, Ph.D. Supervisory Patent Examiner Technology Center 1600 United States Patent.
Examining Claims for Compliance with 35 U.S.C. 112(a): Part II – Enablement Focus on Electrical/Mechanical and Computer/Software-related Claims August.
UNITED STATES PATENT AND TRADEMARK OFFICE
Vector Claims in Gene Therapy Applications: In vivo vs. In vitro Utilities Deborah Reynolds SPE GAU
Patent Application – Invention name here Inventor: Your Name Assignee: Your Name Filed: Today’s date References Cited: Use Google Patent search to find.
1 Enablement Issues in Pharmaceutical Claims Joseph K. M c Kane Supervisory Patent Examiner Art Unit Ardin Marschel Supervisory Patent.
Margaret Polson Polson Intellectual Property Law, PC US Design Patents Overview.
Patents and the Patenting Process Patents and the Inventor’s role in the Patenting Process.
LYDON - TERMINAL DISCLAIMERS1 Terminal Disclaimer (TD) A Terminal Disclaimer states that the patent –will expire on the same date as a related.
BLW 360 – January 27, 2015 Jonathan LA Phillips
10/13/081 PARK - SPEC SAME IN APP & PAT The Specification: Application v. Issued Patent Why is the specification in the application almost exactly identical.
PATENT OFFICE PROSECUTION
Preparing a Patent Application
Processes Which Employ Non-Obvious Products
Legal Trends Regarding Ranges and Anticipation
Ram R. Shukla, Ph.D. SPE AU 1632 & 1634 Technology Center
Group Name Project Title
Nuts and Bolts of Patent Law
Global Innovation Management Workout on Writing a Patent
Quality Assurance Specialist
Stem Cells Peter Paras, Jr.
Preparing a Patent Application
Presentation transcript:

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 1 Examiner Use of Background Statements David Schnapf Sheppard Mullin Richter & Hampton LLP

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 2 37 CFR §1.77 “Arrangement of application elements.” (a) The elements of the application, if applicable, should appear in the following order:... (4) Specification. (b) The specification should include the following sections in order:... (5) Background of the invention.

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 3 MPEP § (a) “ Arrangement of Application” : (e) Background of the Invention: See MPEP § (c). The specification should set forth the Background of the Invention in two parts: … (2) Description of the Related Art: A description of the related art known to the applicant and including, if applicable, references to specific related art and problems involved in the prior art which are solved by the applicant’s invention. This item may also be titled “Background Art.”

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 4 MPEP § (c) “ Background of the Invention” :... (2) Description of the related art including information disclosed under 37 CFR 1.97 and 37 CFR 1.98: A paragraph(s) describing to the extent practical the state of the prior art or other information disclosed known to the applicant, including references to specific prior art or other information where appropriate.

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 5 MPEP § (p) “ Completeness”... “While the prior art setting may be mentioned in general terms, the essential novelty, the essence of the invention, must be described in such details, including proportions and techniques, where necessary, as to enable those persons skilled in the art to make and utilize the invention.”

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 6 There Is No Legal Requirement To Discuss The Prior Art In The Background Of The Invention There Are Substantial Risks Associated With Doing So

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 7 Risks of Discussing Prior Art “Applicant Admitted Prior Art” - “AAPA” Failure to properly delineate what is prior art in Background Inequitable Conduct

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 8 MPEP § 2129 “Admissions as Prior Art - ADMISSIONS BY APPLICANT CONSTITUTE PRIOR ART” –“When applicant states that something is prior art, it is taken as being available as prior art against the claims. Admitted prior art can be used in obviousness rejections. In re Nomiya, 509 F.2d 566, 184 USPQ 607, 610 (CCPA 1975) (Figures in the application labeled “prior art” held to be an admission that what was pictured was prior art relative to applicant’s invention.).”

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 9 AAPA Increased reliance on AAPA in obviousness rejections. Easy for examiner to rely on something that is admitted than to search prior art Risk: Often reasons why combination would not be made are not discussed Risk: Statements often taken out of context

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 10 “Background” Not Always Prior Art Background discussions not always “prior art” –Problems being solved may not be appreciated –Applicant’s own prior work may be described Care required to properly characterize this type of background information

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 11 Inequitable Conduct The following can lead to allegations of Inequitable conduct: –Inaccurate or incorrect discussion of prior art –Failure to discuss most pertinent aspect of prior art reference –Problem compounded if prior art is in Japanese and is understandable to inventors or Japanese patent agents.

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 12 Inequitable Conduct Semiconductor Energy Laboratory Co. v. Samsung Electronics Co. (CAFC 2000) 204 F.3d 1368, 54 USPQ2d 1001 –Patent applicant that submitted … one-page partial translation of entire 29-page reference, since applicant, by submitting partial translation focusing on less material portions of reference, as well as concise statement directed to these less material portions, deliberately deceived examiner into thinking that reference was less material than it really was …

(c) 2004, David Schnapf, Sheppard Mullin Richter & Hampton LLP 13 Inequitable Conduct Semiconductor Energy Laboratory Co. v. Samsung Electronics Co. (CAFC 2000) 204 F.3d 1368, 54 USPQ2d 1001 –The duty of candor … require[s] … that the applicant refrain from submitting partial translations and concise explanations that it knows will misdirect the examiner's attention from the reference's relevant teaching.